Clinical trials in United Kingdom
29,146 studies list at least one site in United Kingdom. 4,038 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Status
Most studied here
Who runs them
AstraZeneca (796) · Imperial College London (776) · GlaxoSmithKline (682) · Novartis Pharmaceuticals (613) · Hoffmann-La Roche (566) · University of Oxford (552) · University College, London (549) · King's College London (441)
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting58
- Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaNov 10, 2026NCT06421649
- Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaNov 10, 2026NCT06434493
- Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaNov 10, 2026NCT06804447
- Women's Knowledge About Induction of Labour and Its Association With Their ExperienceNov 10, 2026NCT07616765
- An Observational Study Into Antimicrobial Resistance in Patients With a Chronic Lung DiseaseNov 10, 2026NCT07646691
Show 45 moreShow fewer
- Immune Reponses to RSV B Challenge in Older Adults (A Controlled Human Infection Study With RSV in Older People-02)Nov 10, 2026NCT07713628
- Why Do People With Epilepsy Get More Infections?Nov 10, 2026NCT07903168
- Study to Test Effects and Safety of RO7568282 in Early Parkinson's DiseaseNov 9, 2026NCT07781644
- PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low MoodNov 9, 2026NCT07848477
- A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsNov 9, 2026NCT07898774
- Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection FractionNov 6, 2026NCT07403058
- Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.Nov 6, 2026NCT07833488
- A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisNov 5, 2026NCT07747480
- Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility StudyNov 5, 2026NCT07874217
- The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsNov 5, 2026NCT07900607
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseaseNov 3, 2026NCT07778667
- A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.Nov 2, 2026NCT07357675
- Outcome Research in Bowel Irrigation Techniques for the Treatment of Chronic Constipation and/or Faecal IncontinenceOct 30, 2026NCT07473622
- The Psychological Effects of Miscarriage Prediction Score: A Prospective StudyOct 29, 2026NCT07609602
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- Cardiovascular Acoustics for Early Disease DetectionOct 28, 2026NCT07496775
- A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and FeasibilityOct 28, 2026NCT07675733
- A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisOct 28, 2026NCT07747467
- A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia AOct 28, 2026NCT07830732
- Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsOct 28, 2026NCT07896252
- Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)Oct 27, 2026NCT06295731
- Comparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community SettingsOct 27, 2026NCT07798596
- Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD)Oct 26, 2026NCT07438951
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)Oct 26, 2026NCT07631637
- Prevent Cognitive Decline in GBA-associated Parkinson's DiseaseOct 23, 2026NCT07055087
- ID93/GLA-SE Vaccination + BCG ChallengeOct 22, 2026NCT06670755
- Oxford Luteal Dysfunction and Placental Insufficiency StudyOct 22, 2026NCT07072052
- OPM- MEG in Non-immune And iMmune-medIated Neurological DiseaseOct 22, 2026NCT07689682
- Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon CancerOct 22, 2026NCT07808151
- Safety, Tolerability, PK, and PD of TGM-148 in Healthy ParticipantsOct 22, 2026NCT07843368
- Evaluation of a Brief Influencer-Delivered Body Image VideoOct 22, 2026NCT07850037
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsOct 21, 2026NCT04557449
- Arterial Stiffness and Endothelial Function in Heart FailureOct 21, 2026NCT07713719
- A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Oct 21, 2026NCT07735637
- Robotic RVO Trial: Robot-assisted Retinal Vein Cannulation in Patients With Retinal Vein OcclusionsOct 21, 2026NCT07820761
- MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's DiseaseOct 21, 2026NCT07838675
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary DiseaseOct 20, 2026NCT07822334
- Mineral-Infused Clothing for Recovery From Muscle Soreness and Muscle Damage After ExerciseOct 20, 2026NCT07873866
- A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATDOct 19, 2026NCT06405633
- A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeOct 19, 2026NCT07344779
- A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing HaemodialysisOct 19, 2026NCT07422532
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesOct 19, 2026NCT07668336
- A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different WaysOct 19, 2026NCT07837648
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Oct 16, 2026NCT06782373
and 8 more not listed
First site in United Kingdom84
- Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaNov 10, 2026NCT06421649
- Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaNov 10, 2026NCT06434493
- Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaNov 10, 2026NCT06804447
- Women's Knowledge About Induction of Labour and Its Association With Their ExperienceNov 10, 2026NCT07616765
- An Observational Study Into Antimicrobial Resistance in Patients With a Chronic Lung DiseaseNov 10, 2026NCT07646691
Show 45 moreShow fewer
- Immune Reponses to RSV B Challenge in Older Adults (A Controlled Human Infection Study With RSV in Older People-02)Nov 10, 2026NCT07713628
- Why Do People With Epilepsy Get More Infections?Nov 10, 2026NCT07903168
- 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk NeuroblastomaNov 9, 2026NCT04903899
- Oxy-PICU Neurodevelopmental Follow-up StudyNov 9, 2026NCT06734715
- Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without PembrolizumabNov 9, 2026NCT07486817
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)Nov 9, 2026NCT07541170
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNov 9, 2026NCT07621809
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)Nov 9, 2026NCT07631637
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1Nov 6, 2026NCT07563881
- Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian CancerNov 6, 2026NCT07851025
- A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCNov 5, 2026NCT07491497
- The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)Nov 5, 2026NCT07671924
- A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisNov 5, 2026NCT07747480
- A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)Nov 5, 2026NCT07776691
- A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseNov 4, 2026NCT07332481
- A Study of Brepocitinib in Adults With Cutaneous SarcoidosisNov 3, 2026NCT06978725
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) AmyloidosisNov 3, 2026NCT07224672
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' DiseaseNov 3, 2026NCT07570316
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseaseNov 3, 2026NCT07778667
- A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeNov 2, 2026NCT07503444
- Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW StudyNov 2, 2026NCT07676097
- Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AMLNov 2, 2026NCT07723703
- AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple MyelomaOct 30, 2026NCT06106945
- Outcome Research in Bowel Irrigation Techniques for the Treatment of Chronic Constipation and/or Faecal IncontinenceOct 30, 2026NCT07473622
- SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose WeightOct 30, 2026NCT07850050
- The Psychological Effects of Miscarriage Prediction Score: A Prospective StudyOct 29, 2026NCT07609602
- NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's DiseaseOct 29, 2026NCT07683325
- A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory MyopathiesOct 29, 2026NCT07789015
- BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid TumoursOct 28, 2026NCT04421820
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Oct 28, 2026NCT06823115
- Cardiovascular Acoustics for Early Disease DetectionOct 28, 2026NCT07496775
- A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisOct 28, 2026NCT07747467
- Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsOct 28, 2026NCT07896252
- Phase 2b Open-Label Repeat Kidney Biopsy StudyOct 27, 2026NCT06740526
- Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD)Oct 26, 2026NCT07438951
- MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without ObinutuzumabOct 23, 2026NCT07024706
- Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.Oct 23, 2026NCT07480395
- A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseaseOct 23, 2026NCT07688213
- A Study of MZE782 in Adults With PKUOct 23, 2026NCT07694440
- A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Oct 23, 2026NCT07705555
- Atrial Fibrillation Driver StudyOct 22, 2026NCT05743829
- Randomised Comparison of the Octaray and Pentaray CathetersOct 22, 2026NCT05988424
- Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery DiseaseOct 22, 2026NCT07318610
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseOct 22, 2026NCT07363694
- A 2-part Phase 1/2 Open-label Trial on ODM-212Oct 22, 2026NCT07563738
and 34 more not listed
Results posted54
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
- Pegcetacoplan Long Term Safety and Efficacy Extension StudyNov 10, 2026NCT03531255
- A Trial of Talabostat (BXCL701) and Pembrolizumab in Participants With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma PhenotypeNov 10, 2026NCT03910660
- Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaNov 9, 2026NCT04091126
- Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464Nov 9, 2026NCT05121714
Show 45 moreShow fewer
- A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital HerpesNov 9, 2026NCT05298254
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNov 9, 2026NCT05936151
- Whole Body MRI for Cancer Surveillance in A-TNov 6, 2026NCT05252819
- Non-Eosinophilic Biological Effects of IL-5Nov 6, 2026NCT06026202
- A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382Nov 6, 2026NCT06032546
- A Phase 3 Study to Assess the Immune Response and Safety of rMenB+OMV NZ in Primed Healthy Participants (10 to 20 Years Old)Nov 6, 2026NCT06995430
- TissuePAtchDS--P ™ PArotidectomy Trial.Nov 5, 2026NCT04116762
- A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNov 5, 2026NCT04619420
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)Nov 5, 2026NCT05620836
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyNov 5, 2026NCT06333808
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantNov 4, 2026NCT04543591
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityOct 30, 2026NCT06046443
- An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDOct 30, 2026NCT06215261
- Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the InvestigatorOct 29, 2026NCT01742299
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaOct 29, 2026NCT06341712
- A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyOct 28, 2026NCT02875548
- Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic MigraineOct 28, 2026NCT03832998
- Ursodeoxycholic Acid vs Metformin in Gestational Diabetes MellitusOct 28, 2026NCT04407650
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisOct 28, 2026NCT05297448
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 DeficiencyOct 27, 2026NCT04686175
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 DiabetesOct 27, 2026NCT05901831
- Semaglutide 2.4 mg in Patients With Poor Weight-lossOct 26, 2026NCT05073835
- The Impact of Chronic Adolescent Skin Conditions on Sexual HealthOct 26, 2026NCT06397664
- Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)Oct 23, 2026NCT03653832
- A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy ParticipantsOct 23, 2026NCT06268860
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)Oct 22, 2026NCT03036488
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsOct 22, 2026NCT04420884
- Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLOct 21, 2026NCT04404283
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)Oct 21, 2026NCT05502341
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)Oct 20, 2026NCT04630028
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- Clinical Study to Investigate the Ability of a Stannous Fluoride Toothpaste to Protect From Dentine HypersensitivityOct 19, 2026NCT06733285
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- Day and Night Closed-loop in Young People With Type 1 DiabetesOct 15, 2026NCT02925299
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Oct 15, 2026NCT04701983
- Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of AgeOct 15, 2026NCT05882357
and 4 more not listed
Stopped16
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
- Long-term Extension of GTX-102 in Angelman SyndromeTerminatedNov 3, 2026NCT06415344
- A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)TerminatedNov 3, 2026NCT07157254
- Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNTerminatedNov 2, 2026NCT06209736
- A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489TerminatedNov 2, 2026NCT07073820
Show 11 moreShow fewer
- An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)TerminatedOct 30, 2026NCT06961344
- A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyTerminatedOct 28, 2026NCT02875548
- Ursodeoxycholic Acid vs Metformin in Gestational Diabetes MellitusTerminatedOct 28, 2026NCT04407650
- A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaTerminatedOct 19, 2026NCT05529316
- ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)TerminatedOct 19, 2026NCT05601752
- Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid TumorsTerminatedOct 19, 2026NCT05800964
- ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 DeficiencyTerminatedOct 19, 2026NCT06462547
- Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedOct 16, 2026NCT05070845
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedOct 15, 2026NCT05268289
- The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 DeficiencyTerminatedOct 15, 2026NCT05734196
- TAK-242 in Patients With Acute Alcoholic HepatitisTerminatedOct 14, 2026NCT04620148
Newly registered64
- Impact of Oral vs. Transdermal Oestrogen on Cortisol & CBG Before SSTNov 10, 2026NCT07928024
- A Study of Brenipatide in Participants With Major Depressive DisorderNov 10, 2026NCT07928245
- A Study of LY4336619 in Adult Participants With Advanced Solid TumorsNov 10, 2026NCT07928258
- Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU AdmissionNov 10, 2026NCT07929506
- Chronic Respiratory Disease Participant Engagement StudyNov 9, 2026NCT07924462
Show 45 moreShow fewer
- Dermal Priming in Enhancing Vaccine ImmunogenicityNov 9, 2026NCT07925996
- SleepCogni: Can the SleepCogni Device (A Handheld Device That Treats Insomnia Using Biofeedback) Improve Sleep in Children With Chronic Insomnia?Nov 9, 2026NCT07926724
- Improving Morning Strength and Cognitive Performance Using Caffeine or Whole-body Vibration.Nov 6, 2026NCT07921810
- Dietary Supplementation and HydrationNov 6, 2026NCT07921914
- To Investigate the Feasibility and Acceptability of Trained Non-medical Professionals Performing Laser Treatment for Proliferative Diabetic Retinopathy (PDR), and the Potential Impact on Service Capacity. Assess Feasibility of Conducting a Full Trial Comparing Trained ECPs With OphthalmologistsNov 6, 2026NCT07923292
- Ergonomic Evaluation of Microscopic Ear Surgery With Exoskeleton: A Single Site Non-blinded StudyNov 5, 2026NCT07919080
- A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy Adult ParticipantsNov 5, 2026NCT07919210
- A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNov 5, 2026NCT07919405
- Non-Invasive Biomarker Monitoring in UC on BiologicsNov 5, 2026NCT07920367
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- Neuromuscular Electrical Stimulation to Improve the Muscle Health of Individuals With Acute Kidney InjuryNov 4, 2026NCT07915713
- Eccentric Exercise in Community-dwelling Older AdultsNov 4, 2026NCT07916935
- Effects of Epetôme on Gastrointestinal Function, Inflammation and Wellbeing in Adults With IBS-like Symptoms (EPEGUT)Nov 4, 2026NCT07916948
- A Study to Evaluate Treating Watery Noses With Cryotherapy in the Clinic Setting. This is Cold Therapy, Freezing the Issues at the Back of the Nose to Ease Symptoms.Nov 4, 2026NCT07917091
- Assessing Blood Pressure Variability in a Healthy Adult Population During Transcutaneous Hypoglossal Nerve Stimulation With the Zeus Sleep DeviceNov 4, 2026NCT07917260
- Implementing Action Falls for Domiciliary CareNov 3, 2026NCT07913373
- Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus StudyNov 3, 2026NCT07913919
- Virtual Reality Assisted Trauma Focused CBTNov 3, 2026NCT07914634
- Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2)Nov 3, 2026NCT07914647
- A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234Nov 2, 2026NCT07911514
- Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)Oct 30, 2026NCT07908108
- Why Do People With Epilepsy Get More Infections?Oct 29, 2026NCT07903168
- Effect of Filter Lifespan in CRRT on New Infections in Critically Ill Patients With AKIOct 29, 2026NCT07903519
- Vascular Health and Function in Cystic FibrosisOct 29, 2026NCT07904325
- Tolerance and Acceptability of an Oral Nutrition SupplementOct 29, 2026NCT07904715
- The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsOct 28, 2026NCT07900607
- A Comparison of Pulsed Field Ablation (PFA) vs Cryoablation for Atrial Fibrillation Under Deep SedationOct 28, 2026NCT07900685
- Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot UlcerationOct 28, 2026NCT07901478
- Monitoring and Early Detection of Treatable Inherited RETinal Disease in Children and AdolescentsOct 28, 2026NCT07901907
- Nasal Residency of HEX17Oct 27, 2026NCT07898306
- A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsOct 27, 2026NCT07898774
- REAL-MS: Observational Database Study of AHSCT and MS TherapiesOct 27, 2026NCT07899502
- Comparing an AI-driven Hearing Test With the Standard Hearing Test in Adults With Hearing Loss and TinnitusOct 26, 2026NCT07895004
- Performance Evaluation of the OCUTOP Hand-held Corneal TopographerOct 26, 2026NCT07895849
- Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsOct 26, 2026NCT07896252
- Preventing Kidney Injury Using Carbon Dioxide as Contrast Medium in Patients With Peripheral Arterial Disease (PAD) and Chronic Kidney Disease (CKD) Having Arterial InterventionOct 23, 2026NCT07891988
- Service Evaluation for Newborn Screening for Spinal Muscular AtrophyOct 22, 2026NCT07888868
- What Should we Measure? A Qualitative Interview Study on Outcomes for Evaluating AI-assisted Medical Image Interpretation.Oct 21, 2026NCT07885150
- Testing a Smartphone App to Support a Mediterranean Diet and Strength ExerciseOct 21, 2026NCT07885254
- Effects of Probiotics on Skin Health in Healthy WomenOct 21, 2026NCT07887841
- Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's DiseaseOct 20, 2026NCT07882108
- Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) DiseaseOct 20, 2026NCT07882290
- Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestOct 20, 2026NCT07883954
- SPutum Induction and Nebuliser deviCEs for Patients With CFOct 19, 2026NCT07879651
- Dual Neuromodulation for Depression: Boosting TMS With tESOct 19, 2026NCT07879924
and 14 more not listed
Studies
Recruiting first, then most recently updated. Showing 50 of 29,146 — search for more.
- A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)Enrolling by invitationNCT06431893Phase 3
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- A Postmarketing Study of LEQEMBI in United Kingdom (UK) Participants With Alzheimer's Disease (AD)Not yet recruitingNCT07781345
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruitingNCT05222529Phase 2
- Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU AdmissionNot yet recruitingNCT07929506Not applicable
- A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)RecruitingNCT06351631Phase 3
- A Study of LY4336619 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07928258Phase 1
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- A Study of Brenipatide in Participants With Major Depressive DisorderNot yet recruitingNCT07928245Phase 2
- Imlifidase Prior to Kidney Transplant in Highly Sensitised ChildrenRecruitingNCT05753930Phase 2
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)RecruitingNCT06345729Phase 3
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 3
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingNCT06651281Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- The PERSEVERE StudyRecruitingNCT06588634Not applicable
- Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaRecruitingNCT06421649Not applicable
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsRecruitingNCT04557449Phase 2
- A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsRecruitingNCT06515613Phase 1
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT05650632Phase 1
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsRecruitingNCT06581432Phase 2
- Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaRecruitingNCT06434493Not applicable
- The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced DiabetesRecruitingNCT06318442Not applicable
- A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerRecruitingNCT06827236Phase 1/2
- Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaRecruitingNCT06804447Not applicable
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).RecruitingNCT06843447Phase 1/2
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)RecruitingNCT06997588Phase 2
- Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson DiseaseRecruitingNCT07227896
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
- Women's Knowledge About Induction of Labour and Its Association With Their ExperienceRecruitingNCT07616765
- An Observational Study Into Antimicrobial Resistance in Patients With a Chronic Lung DiseaseRecruitingNCT07646691
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)RecruitingNCT07286578Not applicable
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyRecruitingNCT07285213Phase 2
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingNCT07555938Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureRecruitingNCT07219459Phase 2
- Immune Reponses to RSV B Challenge in Older Adults (A Controlled Human Infection Study With RSV in Older People-02)RecruitingNCT07713628Not applicable
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3